FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine and biology and is a new agent with apoptosis-inhibiting (anti-apoptotic) activity. Tool can be used to correct conditions associated with an increase in the level of cell apoptosis (oxidative stress, ischemic damage), as well as an inhibitor of apoptosis in cell cultures in vitro. Tool is a crystalline lithium pyruvate of general formula C3H3O3Li.
EFFECT: invention expands the arsenal of agents with apoptosis-inhibiting activity, and can be used in medicine and biology.
1 cl, 1 dwg, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT OF APOPTOSIS-INDUCTIVE ACTIVITY | 2017 |
|
RU2654711C1 |
AGENT POSSESSING CYTOPROTECTIVE ACTION | 2019 |
|
RU2717343C1 |
AGENT AND METHOD FOR APOPTOSIS INDUCTION IN CANCER CELLS | 2012 |
|
RU2488408C1 |
AGENT WITH ANTIAPOPTOTIC ACTIVITY | 2018 |
|
RU2685428C1 |
POTASSIUM CHANNEL INHIBITORS AS THERAPEUTIC AGENTS IN LYMPHOMA AND LEUKAEMIA | 2012 |
|
RU2533288C2 |
APPLICATION OF AGONIST-LIGAND SPECIFIC FOR RAR-γ,-TYPE RECEPTORS FOR APOPTOSIS RATE INCREASE | 1996 |
|
RU2188037C2 |
METHOD OF PREVENTING INACTIVATION OF CELL DEATH CAUSED BY CYTOCHROME C | 2023 |
|
RU2811126C1 |
ANTAGONIST-LIGAND RAR-γ OR AGONIST-LIGAND RAR-α AS INHIBITOR OF APOPTOSIS | 1996 |
|
RU2191008C2 |
PHARMACEUTICAL NEUROPROTECTIVE, ANTIOXIDANT, ANTIHYPOXIC, ANTIAPOPTOTIC AND MEMBRANE PROTECTIVE COMPOSITION AND METHOD OF TREATMENT | 2008 |
|
RU2385722C1 |
APPLICATION OF DNA FRAGMENT OF TRANSCRIBED REGION OF RIBOSOMAL REPEAT TO INCREASE STABILITY OF MESENCHIMAL STEM CELLS TO ACTION OF AGGRESSIVE ENVIRONMENTAL FACTORS | 2013 |
|
RU2560270C2 |
Authors
Dates
2019-01-22—Published
2018-03-28—Filed